Genedrive PLC Director/PDMR Shareholding (6708B)
05 April 2017 - 8:17PM
UK Regulatory
TIDMGDR
RNS Number : 6708B
Genedrive PLC
05 April 2017
Notification and public disclosure of transactions by persons
discharging
managerial responsibilities and persons closely associated with
them
genedrive plc (LSE: GDR) ("genedrive" or the "Company"), the
near patient molecular diagnostics company, announces that it has
granted share options ("Options") to certain of its directors and
senior management to acquire a total of 632,884 ordinary shares of
1.5p each in the capital of the Company under the Company's Share
Option Scheme.
The Options have been granted with an exercise price equal to
the close price on the day before grant and vest after a period of
three years. The Options are exercisable over the period of 10
years from the date of grant.
The information set out below is provided in accordance with the
requirements of Article 19(3) of the EU Market Abuse Regulation No
596/2014.
1. Details of the person discharging managerial
responsibilities / person closely associated
--- -----------------------------------------------------------------------------
a. Name 1. David Budd
2. Allan Brown
3. Gino Miele
--- ------------------------------ ---------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------------------------
a. Position/status 1. Chief Executive Officer
2. Chief Operating Officer
3. R&D Director
--- ------------------------------ ---------------------------------------------
a. Initial notification Initial notification
/Amendment
--- ------------------------------ ---------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------------------------
a. Name genedrive plc
--- ------------------------------ ---------------------------------------------
b. LEI N/A
--- ------------------------------ ---------------------------------------------
4. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------------------------
a. Description Options over ordinary shares of
of the 1.5 pence each
Financial
instrument,
type
of instrument
Identification
code
--- ------------------------------ ---------------------------------------------
b. Nature of Grant of options pursuant to and
the transaction in accordance with the terms of
the Company's Share Option Scheme
dated 28 November 2007.
--- ------------------------------ ---------------------------------------------
c. Price(s) Price(s) Option Volume(s)
and volume(s) price(s)
------------------ ---------- ----------
David Budd 42.5p 397,590
------------------ ---------- ----------
Allan Brown 42.5p 117,647
------------------ ---------- ----------
Gino Miele 42.5p 117,647
------------------ ---------- ----------
--- ------------------------------ ---------------------------------------------
d. Aggregated
information N/A
* Aggregated volume
* Price
--- ------------------------------ ---------------------------------------------
e. Date of the 2016-04-04; UTC time
transaction
--- ------------------------------ ---------------------------------------------
f. Place of Outside trading venue - shares
the transaction to be admitted to AIM market of
London Stock Exchange plc on exercise
of options
--- ------------------------------ ---------------------------------------------
For further details please contact:
genedrive plc +44 (0)161 989 0245
David Budd: CEO
Matthew Fowler: CFO
Peel Hunt LLP +44 (0)207 418 8900
James Steel
Oliver Jackson
Consilium Strategic Communications +44 (0)203 709 5700
Chris Gardner
Matthew Neal
Laura Thornton
genedrive@consilium-comms.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEAELSEFSXEFF
(END) Dow Jones Newswires
April 05, 2017 06:17 ET (10:17 GMT)
Genedrive (LSE:GDR)
Historical Stock Chart
From Apr 2024 to May 2024
Genedrive (LSE:GDR)
Historical Stock Chart
From May 2023 to May 2024